CORD-19:775b90287b44353bee979abb0970a4666022f86d / 765606-765762 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Plasma derived C1-INH products are available in the US for HAE prophylaxis; but are approved for both propylaxis and treatment in eleven European countries.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T46854","span":{"begin":0,"end":156},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T46854","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T315","span":{"begin":0,"end":156},"obj":"Sentence"}],"attributes":[{"subj":"T315","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5766","span":{"begin":59,"end":62},"obj":"Disease"},{"id":"T32926","span":{"begin":59,"end":62},"obj":"Disease"}],"attributes":[{"id":"A5766","pred":"mondo_id","subj":"T5766","obj":"http://purl.obolibrary.org/obo/MONDO_0019623"},{"id":"A72687","pred":"mondo_id","subj":"T32926","obj":"http://purl.obolibrary.org/obo/MONDO_0019623"},{"subj":"T5766","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T32926","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93e0ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ecde93"},{"id":"CORD-19-PD-MONDO","color":"#c493ec"}]}]}}